Navigate Fool.com
Will STEM beat
the market?



Community Rating: 2 Stars: Unattractive

1.25 0.02 (1.63%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.25
Previous Close $1.23
Daily Range $1.22 - $1.26
52-Week Range $1.15 - $1.95
Market Cap $69.3M
P/E Ratio -2.05
Dividend (Yield) $0.00 (0.0%)
Volume 323,820
Average Daily Volume 773,064
Current FY EPS $0.00

How do you think STEM
will perform against the market?

Top STEM Bull/Bear Pitches


zzlangerhans (< 20)
Submitted April 13, 2011

This is a good one, even for baby biotech. Stemcells dropped 15% on Friday after announcing they were canceling a trial of their CNS stem cells in neuronal ceroid lipofuscinosis because they couldn't … More

2 Replies Reply Report this Post

G8BigBoom (< 20)
Submitted March 18, 2009

10 years down the road you will be kicking yourselves for not buying this. On second thought so will I. The technology has shown some very interesting Possible innovations. Talk only goes so far if yo … More

3 Replies Reply Report this Post

News & Commentary Rss Feed

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

New State-Sponsored Stem Cell Study Launches for Alzheimer’s Disease

Geron Earnings: An Early Look

Let's look forward to this company's next earnings report.

Stem Cells Have a Long Way to Go

StemCells produces tantalizing data on its neural stem cell product HuCNS-SC, but don't read too much into it.

Tuesday’s biggest gaining and declining stocks

CAPScall of the Week: Neuralstem

A weekly adventure in giving unknown companies some attention.

5 Things to Watch This Week in the Health-Care Sector

These five news stories have the potential to produce big moves in these stocks.

Midday Nasdaq Stale As Facebook, Intel Flatten Out

Also, StemCells is probably going to save all our lives or something like that.

Tuesday’s biggest gaining and declining stocks


See More STEM News...





STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks